# Dexrazoxane

NDC: 68083-195
Generic name: Dexrazoxane for Injection
Labeler / Manufacturer: Gland Pharma Limited
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAVENOUS
Marketing started: 20161205

FDA application: ANDA207321

## Active ingredients

- DEXRAZOXANE HYDROCHLORIDE: 500 mg/50mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"68083-195"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=68083-195
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c9c625fc-8852-4ed4-bcf2-63f46a706782